https://orcid.org/0000-0001-5457-3443
Figures & data
Figure 1. IPSS categories in the TTh group at baseline and the final recorded visit for each patient. Patients were categorised into mild, moderate, and severe IPSS categories. *Represents significant difference in the number of patients in an IPSS category from the baseline recording to the final recorded visit (p ≤ .05).
Figure 2. IPSS categories in the control group at baseline and the final recorded visit for each patient. Patients were categorised into mild, moderate, and severe IPSS categories. *Represents significant difference in the number of patients in an IPSS category from the baseline recording to the final recorded visit (p ≤ .05).
Figure 3. The percentage of patients that had been prescribed alpha blockers at any point in their life and prescribed during the course of the study period in both the TTh and control groups. *Represents significant difference between the TTh group and the control group (p ≤ .001).
Figure 4. The percentage of patients that had been prescribed 5-alpha-reductase inhibitors at any point in their life and prescribed during the course of the study period in both the TTh and control groups. * Represents significant difference between the TTh group and the control group (p ≤ .001).
Data availability statement
The data supporting this study’s findings are available from the corresponding author upon reasonable request.